ELAN PHARMACEUTICAL INVESTMENTS LTD 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Apr 7, 2004
Insider Transaction Report
Form 4
ELAN CORP PLC
10% Owner
Transactions
- Sale
Common Stock
2004-04-06$3.00/sh−30,000$90,000→ 2,449,936 total(indirect: I) - Sale
Common Stock
2004-04-05$3.00/sh−65,000$195,000→ 2,479,936 total(indirect: I)
Footnotes (1)
- [F1]The securities are beneficially owned indirectly by Elan Corporation, plc and by its wholly-owned subsidiary, Elan International Services, Ltd., and directly by Elan Pharmaceutical Investments, Ltd., a wholly-owned subsidiary of Elan International Services, Ltd.